Trial Profile
Treatment With Medroxyprogesterone Acetate(MPA) Plus Levonorgestrel-releasing Intrauterine System(LNG-IUS) in Young Women With Early Stage Endometrial Cancer: Multicenter Study: Korean Gynecologic Oncology Group Study (KGOG2009)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Levonorgestrel (Primary) ; Medroxyprogesterone (Primary)
- Indications Endometrial cancer
- Focus Therapeutic Use
- 15 May 2012 New trial record